Beranda › Kanker Paru Non-Sel Kecil › West Virginia › Parkersburg
Uji klinis Kanker Paru Non-Sel Kecil di Parkersburg, WV
4 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Parkersburg (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Camden Clark Medical Center, Parkersburg
- Strecker Cancer Center-Belpre, Belpre
- Marietta Memorial Hospital, Marietta · 12 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Strecker Cancer Center-Belpre, Belpre
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Camden Clark Medical Center, Parkersburg
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Strecker Cancer Center-Belpre, Belpre
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Parkersburg
- Kanker Paru7 studi
- Kanker Payudara4 studi
- Melanoma4 studi
- Kanker Ovarium3 studi
- Kanker Kolorektal3 studi
- Kanker Ginjal (Karsinoma Sel Renal)3 studi
- Kanker Kandung Kemih3 studi
- Kanker Prostat3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.